User menu

Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C.

Bibliographic reference Marcellin, Patrick ; Horsmans, Yves ; Nevens, Frederik ; Grange, Jean-Didier ; Bronowicki, Jean-Pierre ; et. al. Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C.. In: Journal of hepatology, Vol. 47, no. 4, p. 476-83 (2007)
Permanent URL http://hdl.handle.net/2078.1/25640